

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic transmission, dopaminergic (GO:0001963) | 6.45475997 |
| 2 | regulation of synapse structural plasticity (GO:0051823) | 6.41087547 |
| 3 | prepulse inhibition (GO:0060134) | 6.27614348 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.90268096 |
| 5 | adenosine receptor signaling pathway (GO:0001973) | 5.70798714 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.59858436 |
| 7 | striatum development (GO:0021756) | 5.44346227 |
| 8 | synaptic vesicle maturation (GO:0016188) | 5.43768943 |
| 9 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.33224197 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.26196705 |
| 11 | complement activation, alternative pathway (GO:0006957) | 5.16871943 |
| 12 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 5.15579072 |
| 13 | regulation of protein activation cascade (GO:2000257) | 5.12236229 |
| 14 | auditory behavior (GO:0031223) | 5.03432869 |
| 15 | blood coagulation, intrinsic pathway (GO:0007597) | 5.02761701 |
| 16 | response to amphetamine (GO:0001975) | 4.95365531 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.93981951 |
| 18 | vocalization behavior (GO:0071625) | 4.89757839 |
| 19 | glyoxylate metabolic process (GO:0046487) | 4.86927442 |
| 20 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.86809127 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.81011752 |
| 22 | epoxygenase P450 pathway (GO:0019373) | 4.80790282 |
| 23 | regulation of fibrinolysis (GO:0051917) | 4.80511084 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.77477884 |
| 25 | drug catabolic process (GO:0042737) | 4.76418383 |
| 26 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.74894587 |
| 27 | regulation of complement activation (GO:0030449) | 4.74855674 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.71925460 |
| 29 | dopamine receptor signaling pathway (GO:0007212) | 4.71848770 |
| 30 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.70821167 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.70018102 |
| 32 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.69463842 |
| 33 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.67875772 |
| 34 | behavioral response to cocaine (GO:0048148) | 4.59307957 |
| 35 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.57311375 |
| 36 | L-phenylalanine catabolic process (GO:0006559) | 4.49464941 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.49464941 |
| 38 | exogenous drug catabolic process (GO:0042738) | 4.49236123 |
| 39 | cAMP catabolic process (GO:0006198) | 4.49215987 |
| 40 | positive regulation of neurotransmitter transport (GO:0051590) | 4.44421697 |
| 41 | negative regulation of fibrinolysis (GO:0051918) | 4.44175538 |
| 42 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.44015381 |
| 43 | urea metabolic process (GO:0019627) | 4.41440073 |
| 44 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 4.38435418 |
| 45 | substrate-independent telencephalic tangential migration (GO:0021826) | 4.38435418 |
| 46 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.32922244 |
| 47 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.32922244 |
| 48 | omega-hydroxylase P450 pathway (GO:0097267) | 4.32918552 |
| 49 | response to auditory stimulus (GO:0010996) | 4.30708527 |
| 50 | regulation of female receptivity (GO:0045924) | 4.26056332 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 4.22742384 |
| 52 | synaptic vesicle exocytosis (GO:0016079) | 4.20996630 |
| 53 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.17826349 |
| 54 | fibrinolysis (GO:0042730) | 4.16511463 |
| 55 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.15087048 |
| 56 | neuron-neuron synaptic transmission (GO:0007270) | 4.11219993 |
| 57 | nitrogen cycle metabolic process (GO:0071941) | 4.10208960 |
| 58 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.07650413 |
| 59 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.05824764 |
| 60 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.04897778 |
| 61 | regulation of glutamate secretion (GO:0014048) | 4.03652174 |
| 62 | protein localization to synapse (GO:0035418) | 4.00528045 |
| 63 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.98762513 |
| 64 | L-phenylalanine metabolic process (GO:0006558) | 3.97212189 |
| 65 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.97212189 |
| 66 | neurotransmitter secretion (GO:0007269) | 3.96565162 |
| 67 | long-term memory (GO:0007616) | 3.96360906 |
| 68 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.96258228 |
| 69 | cyclic nucleotide catabolic process (GO:0009214) | 3.94716867 |
| 70 | peristalsis (GO:0030432) | 3.93962245 |
| 71 | * neuromuscular process controlling balance (GO:0050885) | 3.92717607 |
| 72 | urea cycle (GO:0000050) | 3.92707402 |
| 73 | exploration behavior (GO:0035640) | 3.90656129 |
| 74 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.90228494 |
| 75 | positive regulation of membrane potential (GO:0045838) | 3.89833229 |
| 76 | regulation of neurotransmitter uptake (GO:0051580) | 3.89264563 |
| 77 | transmission of nerve impulse (GO:0019226) | 3.84249854 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.84085932 |
| 79 | neuronal action potential propagation (GO:0019227) | 3.81817091 |
| 80 | neuronal ion channel clustering (GO:0045161) | 3.81625977 |
| 81 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.81491836 |
| 82 | bile acid biosynthetic process (GO:0006699) | 3.81328587 |
| 83 | layer formation in cerebral cortex (GO:0021819) | 3.79068894 |
| 84 | cellular glucuronidation (GO:0052695) | 3.76141983 |
| 85 | synaptic transmission, glutamatergic (GO:0035249) | 3.75735101 |
| 86 | female mating behavior (GO:0060180) | 3.73086443 |
| 87 | visual learning (GO:0008542) | 3.72268332 |
| 88 | negative regulation of cholesterol transport (GO:0032375) | 3.71362939 |
| 89 | negative regulation of sterol transport (GO:0032372) | 3.71362939 |
| 90 | cAMP metabolic process (GO:0046058) | 3.69867037 |
| 91 | protein carboxylation (GO:0018214) | 3.66127120 |
| 92 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.66127120 |
| 93 | regulation of triglyceride catabolic process (GO:0010896) | 3.65289319 |
| 94 | regulation of postsynaptic membrane potential (GO:0060078) | 3.65155366 |
| 95 | regulation of synaptic plasticity (GO:0048167) | 3.65144966 |
| 96 | mechanosensory behavior (GO:0007638) | 3.65023754 |
| 97 | gamma-aminobutyric acid transport (GO:0015812) | 3.63771516 |
| 98 | behavioral fear response (GO:0001662) | 3.63539036 |
| 99 | behavioral defense response (GO:0002209) | 3.63539036 |
| 100 | activation of protein kinase A activity (GO:0034199) | 3.63418483 |
| 101 | drug metabolic process (GO:0017144) | 3.61059856 |
| 102 | negative regulation of dendrite development (GO:2000171) | 3.60457692 |
| 103 | regulation of synaptic vesicle transport (GO:1902803) | 3.59705313 |
| 104 | regulation of protein kinase A signaling (GO:0010738) | 3.57233627 |
| 105 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.50000578 |
| 106 | bile acid metabolic process (GO:0008206) | 3.49643944 |
| 107 | visual behavior (GO:0007632) | 3.48865092 |
| 108 | response to histamine (GO:0034776) | 3.48356980 |
| 109 | regulation of dendritic spine development (GO:0060998) | 3.47967822 |
| 110 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.47516586 |
| 111 | membrane hyperpolarization (GO:0060081) | 3.47160226 |
| 112 | uronic acid metabolic process (GO:0006063) | 3.47097238 |
| 113 | glucuronate metabolic process (GO:0019585) | 3.47097238 |
| 114 | response to amine (GO:0014075) | 3.44400527 |
| 115 | cerebellar granule cell differentiation (GO:0021707) | 3.44039224 |
| 116 | protein activation cascade (GO:0072376) | 3.43255887 |
| 117 | glutamate receptor signaling pathway (GO:0007215) | 3.42823275 |
| 118 | regulation of norepinephrine secretion (GO:0014061) | 3.41460661 |
| 119 | glycine transport (GO:0015816) | 3.38595185 |
| 120 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.36174485 |
| 121 | glutamate secretion (GO:0014047) | 3.35819791 |
| 122 | long-term synaptic potentiation (GO:0060291) | 3.35243751 |
| 123 | mating behavior (GO:0007617) | 3.35114178 |
| 124 | oxidative demethylation (GO:0070989) | 3.32353550 |
| 125 | cAMP biosynthetic process (GO:0006171) | 3.28310504 |
| 126 | drinking behavior (GO:0042756) | 3.26247472 |
| 127 | cGMP metabolic process (GO:0046068) | 3.25191260 |
| 128 | aromatic amino acid family catabolic process (GO:0009074) | 3.24387144 |
| 129 | learning (GO:0007612) | 3.22280561 |
| 130 | negative regulation of blood coagulation (GO:0030195) | 3.21818094 |
| 131 | negative regulation of hemostasis (GO:1900047) | 3.21818094 |
| 132 | fear response (GO:0042596) | 3.20667666 |
| 133 | triglyceride homeostasis (GO:0070328) | 3.19591086 |
| 134 | acylglycerol homeostasis (GO:0055090) | 3.19591086 |
| 135 | ethanol oxidation (GO:0006069) | 3.19134202 |
| 136 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.17738423 |
| 137 | L-amino acid import (GO:0043092) | 3.15941981 |
| 138 | regulation of Rap GTPase activity (GO:0032317) | 3.15653020 |
| 139 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.15286781 |
| 140 | positive regulation of synaptic transmission (GO:0050806) | 3.14962376 |
| 141 | negative regulation of amino acid transport (GO:0051956) | 3.12178728 |
| 142 | serine family amino acid catabolic process (GO:0009071) | 3.08684185 |
| 143 | bile acid and bile salt transport (GO:0015721) | 3.08517296 |
| 144 | serotonin metabolic process (GO:0042428) | 3.08105147 |
| 145 | complement activation (GO:0006956) | 3.06992426 |
| 146 | phosphate ion transmembrane transport (GO:0035435) | 3.06504242 |
| 147 | cellular potassium ion homeostasis (GO:0030007) | 3.05194115 |
| 148 | regulation of bile acid biosynthetic process (GO:0070857) | 3.03812238 |
| 149 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.03083886 |
| 150 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.01901597 |
| 151 | phenylpropanoid metabolic process (GO:0009698) | 2.97892683 |
| 152 | regulation of cholesterol esterification (GO:0010872) | 2.96943675 |
| 153 | response to methylmercury (GO:0051597) | 2.95643589 |
| 154 | plasma lipoprotein particle remodeling (GO:0034369) | 2.92957325 |
| 155 | protein-lipid complex remodeling (GO:0034368) | 2.92957325 |
| 156 | macromolecular complex remodeling (GO:0034367) | 2.92957325 |
| 157 | complement activation, classical pathway (GO:0006958) | 2.91926701 |
| 158 | postsynaptic membrane organization (GO:0001941) | 2.91558380 |
| 159 | negative regulation of protein activation cascade (GO:2000258) | 2.91102020 |
| 160 | negative regulation of wound healing (GO:0061045) | 2.90515703 |
| 161 | low-density lipoprotein particle remodeling (GO:0034374) | 2.90303545 |
| 162 | reverse cholesterol transport (GO:0043691) | 2.89950013 |
| 163 | sodium ion export (GO:0071436) | 2.86072917 |
| 164 | negative regulation of coagulation (GO:0050819) | 2.82558677 |
| 165 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.81482421 |
| 166 | positive regulation of blood coagulation (GO:0030194) | 2.81264044 |
| 167 | positive regulation of hemostasis (GO:1900048) | 2.81264044 |
| 168 | regulation of humoral immune response (GO:0002920) | 2.80435964 |
| 169 | high-density lipoprotein particle remodeling (GO:0034375) | 2.79420311 |
| 170 | amino-acid betaine metabolic process (GO:0006577) | 2.79259732 |
| 171 | primary amino compound metabolic process (GO:1901160) | 2.76285335 |
| 172 | steroid catabolic process (GO:0006706) | 2.74937943 |
| 173 | amino acid import (GO:0043090) | 2.71236110 |
| 174 | nucleobase catabolic process (GO:0046113) | 2.70978003 |
| 175 | phospholipid efflux (GO:0033700) | 2.70901919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.83231892 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 4.27107693 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.46771786 |
| 4 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.18387092 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.15859086 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.10799096 |
| 7 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96745756 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.93861843 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.88927863 |
| 10 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74908180 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74908180 |
| 12 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.73374658 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.70371564 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.63344334 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.62306150 |
| 16 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62109686 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.58507907 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.54189775 |
| 19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44195215 |
| 20 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41091182 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.37383077 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.34221945 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.32749610 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.28647896 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.25984070 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.20380222 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.19345027 |
| 28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17413283 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14376496 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08098871 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.07115839 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.98871777 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.95135425 |
| 34 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.76836549 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67806286 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.67389268 |
| 37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.65975779 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59490542 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55524062 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.50095203 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49247108 |
| 42 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47688632 |
| 43 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.44383699 |
| 44 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.43812214 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43599691 |
| 46 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.39676683 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36793550 |
| 48 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.36322172 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.36101535 |
| 50 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35706534 |
| 51 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35649709 |
| 52 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.33569974 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33418163 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29630615 |
| 55 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28285569 |
| 56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28284811 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28016498 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26491030 |
| 59 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25083137 |
| 60 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25051270 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24321441 |
| 62 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23565389 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23184019 |
| 64 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.22397781 |
| 65 | AR_19668381_ChIP-Seq_PC3_Human | 1.21322366 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16747355 |
| 67 | * GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16740596 |
| 68 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.15536079 |
| 69 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14407300 |
| 70 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13019382 |
| 71 | STAT3_23295773_ChIP-Seq_U87_Human | 1.11045421 |
| 72 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.10672152 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10636454 |
| 74 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.09487018 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08129194 |
| 76 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05799513 |
| 77 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05192363 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05136812 |
| 79 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04390561 |
| 80 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04315945 |
| 81 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.01620139 |
| 82 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00378859 |
| 83 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99240060 |
| 84 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99152235 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98931162 |
| 86 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.98290516 |
| 87 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97085766 |
| 88 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96257354 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95283687 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94973249 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94869369 |
| 92 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94844580 |
| 93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94140552 |
| 94 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.94043503 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93848592 |
| 96 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93015007 |
| 97 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92973006 |
| 98 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.92744417 |
| 99 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91385057 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90780468 |
| 101 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90097713 |
| 102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89909380 |
| 103 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89742526 |
| 104 | * TAF15_26573619_Chip-Seq_HEK293_Human | 0.89657858 |
| 105 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89403716 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89123940 |
| 107 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87832871 |
| 108 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87684330 |
| 109 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.87522530 |
| 110 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.85479661 |
| 111 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85250985 |
| 112 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84951838 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84951838 |
| 114 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.84356043 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84192259 |
| 116 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84163531 |
| 117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82684639 |
| 118 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.82670289 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82444662 |
| 120 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82032337 |
| 121 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81508047 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81069083 |
| 123 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.80809084 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80504555 |
| 125 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.80442378 |
| 126 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80199167 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.80192936 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79987448 |
| 129 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.79145632 |
| 130 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.79131219 |
| 131 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.78854142 |
| 132 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.78343721 |
| 133 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.78187838 |
| 134 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77690156 |
| 135 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.77573450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 9.54680817 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 6.34226708 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.66392543 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.08440497 |
| 5 | MP0003880_abnormal_central_pattern | 3.99876012 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.79271115 |
| 7 | MP0009745_abnormal_behavioral_response | 3.73391991 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.48412179 |
| 9 | MP0005365_abnormal_bile_salt | 3.37510808 |
| 10 | MP0003868_abnormal_feces_composition | 3.33808812 |
| 11 | MP0004270_analgesia | 3.25245589 |
| 12 | MP0003195_calcinosis | 2.96148482 |
| 13 | MP0002064_seizures | 2.95778498 |
| 14 | MP0001529_abnormal_vocalization | 2.93222358 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.79731310 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.77471849 |
| 17 | MP0009046_muscle_twitch | 2.76198805 |
| 18 | MP0001486_abnormal_startle_reflex | 2.76127319 |
| 19 | MP0005360_urolithiasis | 2.72267783 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 2.63178284 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.52902087 |
| 22 | MP0002272_abnormal_nervous_system | 2.43112679 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.39476793 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.37681258 |
| 25 | MP0005646_abnormal_pituitary_gland | 2.14974902 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.03899366 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.01839362 |
| 28 | MP0002876_abnormal_thyroid_physiology | 2.00699148 |
| 29 | MP0004924_abnormal_behavior | 1.99377003 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.99377003 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.95329488 |
| 32 | MP0003252_abnormal_bile_duct | 1.89818999 |
| 33 | MP0005409_darkened_coat_color | 1.88301554 |
| 34 | MP0010329_abnormal_lipoprotein_level | 1.82648426 |
| 35 | MP0001970_abnormal_pain_threshold | 1.74567586 |
| 36 | MP0008569_lethality_at_weaning | 1.69858285 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.67872907 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.67303612 |
| 39 | MP0002557_abnormal_social/conspecific_i | 1.64487144 |
| 40 | MP0001984_abnormal_olfaction | 1.63082210 |
| 41 | MP0003075_altered_response_to | 1.54610484 |
| 42 | MP0003011_delayed_dark_adaptation | 1.52944616 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.51908490 |
| 44 | MP0002736_abnormal_nociception_after | 1.51875201 |
| 45 | MP0001188_hyperpigmentation | 1.50250124 |
| 46 | MP0001440_abnormal_grooming_behavior | 1.49550737 |
| 47 | MP0003879_abnormal_hair_cell | 1.39242014 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.39007656 |
| 49 | MP0008874_decreased_physiological_sensi | 1.37963194 |
| 50 | MP0001986_abnormal_taste_sensitivity | 1.37775978 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.36198331 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.35765951 |
| 53 | MP0004885_abnormal_endolymph | 1.34476740 |
| 54 | MP0004510_myositis | 1.34138013 |
| 55 | MP0003633_abnormal_nervous_system | 1.33926307 |
| 56 | MP0010368_abnormal_lymphatic_system | 1.32359777 |
| 57 | MP0001177_atelectasis | 1.32314551 |
| 58 | MP0008872_abnormal_physiological_respon | 1.31678681 |
| 59 | MP0003329_amyloid_beta_deposits | 1.31122354 |
| 60 | MP0000013_abnormal_adipose_tissue | 1.31002313 |
| 61 | MP0002066_abnormal_motor_capabilities/c | 1.26516373 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.22852008 |
| 63 | MP0000955_abnormal_spinal_cord | 1.20714097 |
| 64 | MP0001905_abnormal_dopamine_level | 1.20669244 |
| 65 | MP0005187_abnormal_penis_morphology | 1.19563869 |
| 66 | MP0002184_abnormal_innervation | 1.17113129 |
| 67 | MP0005248_abnormal_Harderian_gland | 1.15881047 |
| 68 | MP0002735_abnormal_chemical_nociception | 1.12912029 |
| 69 | MP0004130_abnormal_muscle_cell | 1.12888335 |
| 70 | MP0003283_abnormal_digestive_organ | 1.12610634 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.09674674 |
| 72 | MP0002882_abnormal_neuron_morphology | 1.07900054 |
| 73 | MP0010386_abnormal_urinary_bladder | 1.06961545 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.06520714 |
| 75 | MP0003690_abnormal_glial_cell | 1.05052624 |
| 76 | MP0009697_abnormal_copulation | 1.04867021 |
| 77 | MP0004085_abnormal_heartbeat | 1.04147190 |
| 78 | MP0002249_abnormal_larynx_morphology | 1.02168244 |
| 79 | MP0009840_abnormal_foam_cell | 1.02132229 |
| 80 | MP0004019_abnormal_vitamin_homeostasis | 1.01760918 |
| 81 | MP0003631_nervous_system_phenotype | 1.01635755 |
| 82 | MP0004858_abnormal_nervous_system | 0.99844958 |
| 83 | MP0000778_abnormal_nervous_system | 0.99234878 |
| 84 | MP0002090_abnormal_vision | 0.97693026 |
| 85 | MP0000569_abnormal_digit_pigmentation | 0.93594813 |
| 86 | MP0002069_abnormal_eating/drinking_beha | 0.93451783 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.93359632 |
| 88 | MP0005535_abnormal_body_temperature | 0.92070675 |
| 89 | MP0000920_abnormal_myelination | 0.88785784 |
| 90 | MP0001502_abnormal_circadian_rhythm | 0.87448070 |
| 91 | MP0002152_abnormal_brain_morphology | 0.86193690 |
| 92 | MP0005332_abnormal_amino_acid | 0.85645489 |
| 93 | MP0004142_abnormal_muscle_tone | 0.82631001 |
| 94 | MP0000751_myopathy | 0.76114514 |
| 95 | MP0003137_abnormal_impulse_conducting | 0.72774323 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.72175425 |
| 97 | MP0005499_abnormal_olfactory_system | 0.72175425 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 0.71011317 |
| 99 | MP0003787_abnormal_imprinting | 0.70315851 |
| 100 | MP0002229_neurodegeneration | 0.68578626 |
| 101 | MP0003634_abnormal_glial_cell | 0.66008363 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.65962666 |
| 103 | MP0010030_abnormal_orbit_morphology | 0.65887815 |
| 104 | MP0005166_decreased_susceptibility_to | 0.65158363 |
| 105 | MP0000604_amyloidosis | 0.60968906 |
| 106 | MP0003638_abnormal_response/metabolism_ | 0.59879110 |
| 107 | MP0004147_increased_porphyrin_level | 0.57207666 |
| 108 | MP0000609_abnormal_liver_physiology | 0.56868693 |
| 109 | MP0001963_abnormal_hearing_physiology | 0.55292236 |
| 110 | MP0001664_abnormal_digestion | 0.54818831 |
| 111 | MP0004043_abnormal_pH_regulation | 0.53827065 |
| 112 | MP0003122_maternal_imprinting | 0.53362609 |
| 113 | MP0003632_abnormal_nervous_system | 0.51998416 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.51201312 |
| 115 | MP0000003_abnormal_adipose_tissue | 0.49417788 |
| 116 | MP0006276_abnormal_autonomic_nervous | 0.47929128 |
| 117 | MP0005551_abnormal_eye_electrophysiolog | 0.47638380 |
| 118 | MP0001943_abnormal_respiration | 0.46414718 |
| 119 | MP0003956_abnormal_body_size | 0.44525298 |
| 120 | MP0003303_peritoneal_inflammation | 0.44392407 |
| 121 | MP0004742_abnormal_vestibular_system | 0.44214815 |
| 122 | MP0005620_abnormal_muscle_contractility | 0.39724328 |
| 123 | MP0010769_abnormal_survival | 0.38309235 |
| 124 | MP0005623_abnormal_meninges_morphology | 0.36517445 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.36495227 |
| 126 | MP0010770_preweaning_lethality | 0.36323546 |
| 127 | MP0002082_postnatal_lethality | 0.36323546 |
| 128 | MP0002752_abnormal_somatic_nervous | 0.36312995 |
| 129 | MP0003172_abnormal_lysosome_physiology | 0.35732842 |
| 130 | MP0010768_mortality/aging | 0.35270304 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.34365555 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.33791055 |
| 133 | MP0004233_abnormal_muscle_weight | 0.33545255 |
| 134 | MP0000534_abnormal_ureter_morphology | 0.33270153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.83549212 |
| 2 | Focal motor seizures (HP:0011153) | 7.66692932 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.55726840 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.54444331 |
| 5 | Complement deficiency (HP:0004431) | 6.42624753 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.05199263 |
| 7 | Focal seizures (HP:0007359) | 5.65413286 |
| 8 | Abnormality of complement system (HP:0005339) | 5.00484009 |
| 9 | Resting tremor (HP:0002322) | 4.86034582 |
| 10 | Torticollis (HP:0000473) | 4.77863741 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 4.75818646 |
| 12 | Annular pancreas (HP:0001734) | 4.73733471 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.61247186 |
| 14 | Poor eye contact (HP:0000817) | 4.27801764 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.14542042 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.12310624 |
| 17 | Visual hallucinations (HP:0002367) | 4.09802480 |
| 18 | Focal dystonia (HP:0004373) | 4.08298537 |
| 19 | Joint hemorrhage (HP:0005261) | 4.05014231 |
| 20 | Action tremor (HP:0002345) | 4.04582072 |
| 21 | Craniofacial dystonia (HP:0012179) | 4.03656635 |
| 22 | Ankle clonus (HP:0011448) | 3.97794085 |
| 23 | Anxiety (HP:0000739) | 3.96851325 |
| 24 | Glomerulonephritis (HP:0000099) | 3.87970495 |
| 25 | Abnormal social behavior (HP:0012433) | 3.86530152 |
| 26 | Impaired social interactions (HP:0000735) | 3.86530152 |
| 27 | Ankyloglossia (HP:0010296) | 3.82710465 |
| 28 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.81612375 |
| 29 | Menorrhagia (HP:0000132) | 3.70862171 |
| 30 | Depression (HP:0000716) | 3.68193058 |
| 31 | Spontaneous abortion (HP:0005268) | 3.63345799 |
| 32 | Broad-based gait (HP:0002136) | 3.63187839 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.62332698 |
| 34 | Dysdiadochokinesis (HP:0002075) | 3.49948165 |
| 35 | Abnormality of binocular vision (HP:0011514) | 3.49154648 |
| 36 | Diplopia (HP:0000651) | 3.49154648 |
| 37 | Xanthomatosis (HP:0000991) | 3.48543107 |
| 38 | Epileptic encephalopathy (HP:0200134) | 3.43554878 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.39327748 |
| 40 | Generalized tonic-clonic seizures (HP:0002069) | 3.37793668 |
| 41 | Purpura (HP:0000979) | 3.34443095 |
| 42 | Papilledema (HP:0001085) | 3.33402355 |
| 43 | Stereotypic behavior (HP:0000733) | 3.23131300 |
| 44 | Gaze-evoked nystagmus (HP:0000640) | 3.19894955 |
| 45 | Pointed chin (HP:0000307) | 3.19596234 |
| 46 | Absence seizures (HP:0002121) | 3.17490021 |
| 47 | Febrile seizures (HP:0002373) | 3.17273382 |
| 48 | Lower limb amyotrophy (HP:0007210) | 3.15835613 |
| 49 | Urinary urgency (HP:0000012) | 3.15007605 |
| 50 | Osteomalacia (HP:0002749) | 3.11552293 |
| 51 | Polygenic inheritance (HP:0010982) | 3.09737472 |
| 52 | Scanning speech (HP:0002168) | 3.07513651 |
| 53 | Prolonged QT interval (HP:0001657) | 3.06653111 |
| 54 | Postural instability (HP:0002172) | 3.02033435 |
| 55 | Dysmetric saccades (HP:0000641) | 3.01771065 |
| 56 | Dialeptic seizures (HP:0011146) | 2.98404953 |
| 57 | Dysmetria (HP:0001310) | 2.97456440 |
| 58 | Intrahepatic cholestasis (HP:0001406) | 2.94982000 |
| 59 | Atrioventricular block (HP:0001678) | 2.93552596 |
| 60 | Abnormality of oral frenula (HP:0000190) | 2.86218465 |
| 61 | Truncal ataxia (HP:0002078) | 2.81303639 |
| 62 | Conjugated hyperbilirubinemia (HP:0002908) | 2.79924262 |
| 63 | Atonic seizures (HP:0010819) | 2.77950907 |
| 64 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.77258699 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.74326932 |
| 66 | Abnormal EKG (HP:0003115) | 2.72646182 |
| 67 | Gingival bleeding (HP:0000225) | 2.72441603 |
| 68 | Intention tremor (HP:0002080) | 2.71167994 |
| 69 | Spastic gait (HP:0002064) | 2.69819445 |
| 70 | Supranuclear gaze palsy (HP:0000605) | 2.69262644 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.66386496 |
| 72 | Megalencephaly (HP:0001355) | 2.65237169 |
| 73 | Limb dystonia (HP:0002451) | 2.63871289 |
| 74 | Impaired smooth pursuit (HP:0007772) | 2.63074768 |
| 75 | Progressive cerebellar ataxia (HP:0002073) | 2.62600857 |
| 76 | Nephritis (HP:0000123) | 2.61013417 |
| 77 | Distal lower limb amyotrophy (HP:0008944) | 2.60653146 |
| 78 | Impaired vibratory sensation (HP:0002495) | 2.59607224 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55173127 |
| 80 | Increased mean platelet volume (HP:0011877) | 2.54983573 |
| 81 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.50534396 |
| 82 | Bradykinesia (HP:0002067) | 2.50045790 |
| 83 | Heart block (HP:0012722) | 2.45482171 |
| 84 | Limb hypertonia (HP:0002509) | 2.43830227 |
| 85 | Clonus (HP:0002169) | 2.43441108 |
| 86 | Mutism (HP:0002300) | 2.42696065 |
| 87 | Distal upper limb amyotrophy (HP:0007149) | 2.38242887 |
| 88 | Upper limb amyotrophy (HP:0009129) | 2.38242887 |
| 89 | Abnormality of the lower motor neuron (HP:0002366) | 2.36403489 |
| 90 | Abnormal platelet volume (HP:0011876) | 2.34754724 |
| 91 | Abnormality of the intrinsic pathway (HP:0010989) | 2.29101483 |
| 92 | Arthropathy (HP:0003040) | 2.27944481 |
| 93 | Ventricular fibrillation (HP:0001663) | 2.27585246 |
| 94 | Epistaxis (HP:0000421) | 2.27285977 |
| 95 | Incomplete penetrance (HP:0003829) | 2.25534601 |
| 96 | Rickets (HP:0002748) | 2.24521665 |
| 97 | Axonal loss (HP:0003447) | 2.23369798 |
| 98 | Abnormal atrioventricular conduction (HP:0005150) | 2.23311133 |
| 99 | Amblyopia (HP:0000646) | 2.23105835 |
| 100 | Hypolipoproteinemia (HP:0010981) | 2.19380881 |
| 101 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.17895691 |
| 102 | Lower limb muscle weakness (HP:0007340) | 2.16501543 |
| 103 | Status epilepticus (HP:0002133) | 2.16210810 |
| 104 | Obstructive sleep apnea (HP:0002870) | 2.15868627 |
| 105 | Hyperventilation (HP:0002883) | 2.15862227 |
| 106 | Progressive inability to walk (HP:0002505) | 2.15433589 |
| 107 | Truncus arteriosus (HP:0001660) | 2.13498043 |
| 108 | Epidermoid cyst (HP:0200040) | 2.10956722 |
| 109 | Hemiplegia (HP:0002301) | 2.10636344 |
| 110 | Neurofibrillary tangles (HP:0002185) | 2.08661256 |
| 111 | Abnormal gallbladder physiology (HP:0012438) | 2.08069983 |
| 112 | Cholecystitis (HP:0001082) | 2.08069983 |
| 113 | Polyphagia (HP:0002591) | 2.07755469 |
| 114 | Termporal pattern (HP:0011008) | 2.07315350 |
| 115 | Insidious onset (HP:0003587) | 2.07315350 |
| 116 | Abnormality of the periventricular white matter (HP:0002518) | 2.07038169 |
| 117 | Hemiparesis (HP:0001269) | 2.06095283 |
| 118 | Lower limb asymmetry (HP:0100559) | 2.05519068 |
| 119 | Hypophosphatemic rickets (HP:0004912) | 2.01111690 |
| 120 | Neuronal loss in central nervous system (HP:0002529) | 2.01090007 |
| 121 | Bowel incontinence (HP:0002607) | 2.00963337 |
| 122 | Bundle branch block (HP:0011710) | 1.99824139 |
| 123 | Abnormality of saccadic eye movements (HP:0000570) | 1.96035975 |
| 124 | Fair hair (HP:0002286) | 1.94295574 |
| 125 | Dysphonia (HP:0001618) | 1.92969238 |
| 126 | Generalized hypopigmentation of hair (HP:0011358) | 1.92608136 |
| 127 | Poikilocytosis (HP:0004447) | 1.92541572 |
| 128 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.91848826 |
| 129 | Cerebral inclusion bodies (HP:0100314) | 1.91776592 |
| 130 | Onion bulb formation (HP:0003383) | 1.90705679 |
| 131 | Blue irides (HP:0000635) | 1.88636357 |
| 132 | Obsessive-compulsive behavior (HP:0000722) | 1.88407835 |
| 133 | Spinal canal stenosis (HP:0003416) | 1.87436115 |
| 134 | Petechiae (HP:0000967) | 1.86977323 |
| 135 | Genetic anticipation (HP:0003743) | 1.86249816 |
| 136 | Insomnia (HP:0100785) | 1.86163882 |
| 137 | Fetal akinesia sequence (HP:0001989) | 1.85509054 |
| 138 | Pulmonary embolism (HP:0002204) | 1.84974397 |
| 139 | Primary atrial arrhythmia (HP:0001692) | 1.84117331 |
| 140 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83636555 |
| 141 | Epileptiform EEG discharges (HP:0011182) | 1.83554290 |
| 142 | Tetraplegia (HP:0002445) | 1.83470657 |
| 143 | Abnormal large intestine physiology (HP:0012700) | 1.83373468 |
| 144 | Hypsarrhythmia (HP:0002521) | 1.82788305 |
| 145 | Rigidity (HP:0002063) | 1.82719433 |
| 146 | Atrial fibrillation (HP:0005110) | 1.80926795 |
| 147 | Akinesia (HP:0002304) | 1.77822962 |
| 148 | Generalized aminoaciduria (HP:0002909) | 1.77346164 |
| 149 | Mitral stenosis (HP:0001718) | 1.75731670 |
| 150 | Hyperammonemia (HP:0001987) | 1.73455396 |
| 151 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.72598073 |
| 152 | Irritability (HP:0000737) | 1.72398352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 8.22264969 |
| 2 | NTRK3 | 3.87215401 |
| 3 | MAP3K9 | 3.54129446 |
| 4 | CASK | 3.19526282 |
| 5 | KSR2 | 2.94709537 |
| 6 | DAPK2 | 2.94452425 |
| 7 | PRKD3 | 2.64339095 |
| 8 | RIPK4 | 2.62594147 |
| 9 | CAMKK1 | 2.50802830 |
| 10 | MINK1 | 2.08013940 |
| 11 | NTRK1 | 1.97760671 |
| 12 | MAP3K13 | 1.96757405 |
| 13 | FES | 1.94372137 |
| 14 | TAOK1 | 1.92110527 |
| 15 | ARAF | 1.89766839 |
| 16 | NTRK2 | 1.82703067 |
| 17 | KSR1 | 1.79855679 |
| 18 | MARK1 | 1.78503574 |
| 19 | MAP3K4 | 1.74082295 |
| 20 | MAP3K2 | 1.65547893 |
| 21 | PAK6 | 1.63871112 |
| 22 | CAMKK2 | 1.63333434 |
| 23 | CDK5 | 1.60716323 |
| 24 | DAPK1 | 1.54661755 |
| 25 | TYRO3 | 1.46099961 |
| 26 | LATS2 | 1.45388996 |
| 27 | TNIK | 1.43382948 |
| 28 | SIK2 | 1.37818250 |
| 29 | RAF1 | 1.29981240 |
| 30 | MAP2K7 | 1.18894487 |
| 31 | PRPF4B | 1.14057155 |
| 32 | PINK1 | 1.06269095 |
| 33 | MAP3K11 | 1.04907158 |
| 34 | SGK494 | 1.03672272 |
| 35 | SGK223 | 1.03672272 |
| 36 | STK38 | 1.02877824 |
| 37 | PRKCH | 1.02231186 |
| 38 | BMPR2 | 1.00684667 |
| 39 | MAP2K4 | 0.98807639 |
| 40 | MAPK12 | 0.98728740 |
| 41 | NEK1 | 0.93800369 |
| 42 | MARK2 | 0.90690359 |
| 43 | CAMK1G | 0.90626661 |
| 44 | SGK2 | 0.89774178 |
| 45 | SGK3 | 0.88895790 |
| 46 | STK11 | 0.86957864 |
| 47 | PKN1 | 0.84126461 |
| 48 | CDK18 | 0.84034196 |
| 49 | CDK15 | 0.84001402 |
| 50 | UHMK1 | 0.82292589 |
| 51 | RIPK1 | 0.82103803 |
| 52 | PDPK1 | 0.82013545 |
| 53 | SGK1 | 0.81936753 |
| 54 | RET | 0.81626650 |
| 55 | PRKCG | 0.81240860 |
| 56 | CDK14 | 0.80445379 |
| 57 | MAP3K1 | 0.79909721 |
| 58 | DYRK1A | 0.79553220 |
| 59 | ALK | 0.78550091 |
| 60 | EPHA3 | 0.75282981 |
| 61 | PDK1 | 0.75171685 |
| 62 | CCNB1 | 0.74378206 |
| 63 | CDK11A | 0.73017732 |
| 64 | CAMK1 | 0.71970546 |
| 65 | TRIB3 | 0.70929975 |
| 66 | CAMK1D | 0.69681910 |
| 67 | CAMK2A | 0.68872969 |
| 68 | PIK3CA | 0.68663135 |
| 69 | PRKG1 | 0.67961549 |
| 70 | PAK3 | 0.67409181 |
| 71 | CAMK2B | 0.66551058 |
| 72 | PNCK | 0.65601102 |
| 73 | TNK2 | 0.65247994 |
| 74 | SYK | 0.65043738 |
| 75 | JAK2 | 0.64648638 |
| 76 | MAP2K1 | 0.64423113 |
| 77 | PIK3CG | 0.63517122 |
| 78 | PTK2B | 0.63396004 |
| 79 | MAPK13 | 0.63271794 |
| 80 | NEK6 | 0.62915593 |
| 81 | BRSK1 | 0.60369576 |
| 82 | GRK5 | 0.56736144 |
| 83 | DAPK3 | 0.56665224 |
| 84 | LMTK2 | 0.56566174 |
| 85 | FYN | 0.55463216 |
| 86 | RPS6KA3 | 0.54453910 |
| 87 | PRKD2 | 0.54403508 |
| 88 | ERBB2 | 0.54323089 |
| 89 | PRKCZ | 0.53759701 |
| 90 | SCYL2 | 0.51098728 |
| 91 | DMPK | 0.50022637 |
| 92 | JAK1 | 0.49964274 |
| 93 | CSNK1D | 0.49307862 |
| 94 | MAP3K12 | 0.49256400 |
| 95 | CAMK4 | 0.47656698 |
| 96 | MOS | 0.46787143 |
| 97 | MAPK10 | 0.46174163 |
| 98 | MAP3K5 | 0.45642196 |
| 99 | WNK1 | 0.42325593 |
| 100 | PHKG2 | 0.42259932 |
| 101 | PHKG1 | 0.42259932 |
| 102 | CDK19 | 0.42008029 |
| 103 | FGFR2 | 0.39949358 |
| 104 | INSRR | 0.39932733 |
| 105 | BRAF | 0.39709609 |
| 106 | PLK2 | 0.38113319 |
| 107 | SRC | 0.36277792 |
| 108 | OXSR1 | 0.35948837 |
| 109 | PDGFRA | 0.35073455 |
| 110 | PRKCB | 0.34352945 |
| 111 | CAMK2G | 0.31541349 |
| 112 | HCK | 0.30206689 |
| 113 | CDC42BPA | 0.29894116 |
| 114 | PRKCE | 0.29733967 |
| 115 | CSNK1A1 | 0.28789241 |
| 116 | CAMK2D | 0.28776658 |
| 117 | PRKACG | 0.28629376 |
| 118 | CSNK1G2 | 0.27941759 |
| 119 | BMX | 0.26771831 |
| 120 | RPS6KA2 | 0.26752802 |
| 121 | MAPK8 | 0.26422679 |
| 122 | PRKACA | 0.26045726 |
| 123 | PRKD1 | 0.24562974 |
| 124 | PRKCA | 0.24095413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 3.88922591 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.45494606 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.34412020 |
| 4 | Morphine addiction_Homo sapiens_hsa05032 | 2.96854432 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90819079 |
| 6 | Cocaine addiction_Homo sapiens_hsa05030 | 2.81919663 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.80953086 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75943722 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.74387161 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.69039863 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.60088518 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.56987751 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.56878583 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.49236395 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.47654799 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 2.46925288 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.41320980 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.31082213 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.29186067 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.10737687 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 2.06771888 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 2.04631352 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03979126 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99331656 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95691228 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.91631573 |
| 27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88063554 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.79864462 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.78638988 |
| 30 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.75729721 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.74751010 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72713701 |
| 33 | Insulin secretion_Homo sapiens_hsa04911 | 1.70549516 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.67598840 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.67054939 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.60923704 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55413467 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.55265130 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52491971 |
| 40 | Long-term depression_Homo sapiens_hsa04730 | 1.49620162 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.46750923 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.42093769 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.40919860 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.39339816 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 1.34550786 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.34115923 |
| 47 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.33881838 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.30366537 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29418932 |
| 50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24277565 |
| 51 | Glioma_Homo sapiens_hsa05214 | 1.20789324 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.19905714 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.13497502 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10765896 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10578641 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06769896 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05579266 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05439995 |
| 59 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05262602 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05117540 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04815083 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03498998 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.01595634 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99249866 |
| 65 | Alcoholism_Homo sapiens_hsa05034 | 0.98996511 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.95152372 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94528971 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.94049339 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.93189944 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90164894 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89824981 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88838076 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85775481 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84798529 |
| 75 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.84773617 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.84027446 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80838120 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79969099 |
| 79 | Axon guidance_Homo sapiens_hsa04360 | 0.79499923 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79037907 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.78601403 |
| 82 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78477785 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73503025 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73057298 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72459861 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71451226 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70063201 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69440988 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68293849 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68018861 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67115333 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66659979 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66533626 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66253198 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64522119 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63755088 |
| 97 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61163033 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.59273123 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.59025486 |
| 100 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58827629 |
| 101 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58641486 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55972293 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.54782745 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54413539 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53801705 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.51593898 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51263337 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50636890 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.49661622 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49239445 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48772731 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.48055381 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47547617 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47490017 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46927671 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46324844 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44690732 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44515677 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41706688 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41207667 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40033805 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39841136 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39441772 |
| 124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38462733 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38003649 |
| 126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.37195186 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36441633 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35718810 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.35635671 |
| 130 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35533674 |
| 131 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.34105020 |
| 132 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33957291 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33362992 |
| 134 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.30258855 |
| 135 | Pertussis_Homo sapiens_hsa05133 | 0.29391036 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28978290 |
| 137 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28782692 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27079776 |
| 139 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.26408423 |
| 140 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25366778 |
| 141 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.25063768 |
| 142 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24953721 |
| 143 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.23929205 |

